Equity Overview
Price & Market Data
Price: $29.05
Daily Change: -$5.53 / 19.05%
Range: $29.00 - $34.75
Market Cap: $3,086,545,152
Volume: 811,559
Performance Metrics
1 Week: 6.88%
1 Month: 19.97%
3 Months: 16.54%
6 Months: 43.65%
1 Year: 43.65%
YTD: 10.87%
Company Details
Employees: 81
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.